Steven Dunn

2.8K posts

Steven Dunn

Steven Dunn

@CardiacRX

Cardiology Clinical Pharmacist with @UVA and @uvahealthnews. Associate Editor @JACCJournals #JACCEdge. Tweets represent own views and opinions. Sometimes silly.

Charlottesville, Virginia Katılım Eylül 2013
184 Takip Edilen1.1K Takipçiler
Steven Dunn
Steven Dunn@CardiacRX·
@Jcuttsy013 Best I can offer is some NIL money with Higher Grounds.
English
0
0
1
30
Jamey Cutts, MD
Jamey Cutts, MD@Jcuttsy013·
If anyone is offering $8 million for a transfer, I’d like to formally enter the portal with 7 months of advanced cardiac imaging training eligibility remaining…
English
2
0
4
316
Steven Dunn
Steven Dunn@CardiacRX·
This story goes all the way back to RALES but very good reason behind MRA mortality benefit in HF may be achieving higher K lvls. Very cool study but are results due to higher MRA use or higher K? nejm.org/doi/pdf/10.105…
English
0
1
4
51
Steven Dunn
Steven Dunn@CardiacRX·
@drjohnm @theheartorg Secondarily there probably isn’t any more appetite for a digitoxin NDA in the US than there is with vericiguat so I don’t see why this changes anything for a HF practitioner.
English
0
0
0
103
Steven Dunn
Steven Dunn@CardiacRX·
@drjohnm @theheartorg Mortality is still the most important thing in chronic HF. At best this at least shows the digitalis benefit in the face of background beta blocker therapy. We’d do far better increase our (poor) utilization or mortality lowering therapy than messing with dig.
English
1
0
2
917
John Mandrola, MD
John Mandrola, MD@drjohnm·
Darn it. There’s no editorial. Why? Because the heart failure community is stunned. They are speechless. No worries. You can read this (slightly biased) editorial for free on @theheartorg medscape.com/viewarticle/fi… #esccongress #esc2025
NEJM@NEJM

Presented at #ESCCongress: In patients with heart failure and reduced ejection fraction who were receiving guideline-directed medical therapy, digitoxin lowered the risk of death or hospitalization for heart failure as compared with placebo. Full DIGIT-HF phase 4 trial results: nej.md/3HQHLfj @escardio

English
10
32
163
36.6K
Steven Dunn
Steven Dunn@CardiacRX·
@robdeedo @Cait_Centra Cost will absolutely be an issue with finerenone. Can’t imagine there won’t be a consistent PA or copay tier barring new data. They need to more definitively prove safety advantage especially vs generic eplerenone Otherwise little wrong with spirono from my POV if we’re smart
English
0
0
0
52
Rob DiDomenico
Rob DiDomenico@robdeedo·
@Cait_Centra Sooo, now with 3 MRAs from which to select, excluding cost as an obvious barrier, which would you choose and why? (Rhetorical ?, not directed specifically to @Cait_Centra)
English
2
0
0
84
Steven Dunn
Steven Dunn@CardiacRX·
@MartenHawkins It’s great! Start with the interquel - the Heart of What Was Lost and go from there!
English
0
0
0
35
Marten Hawkins
Marten Hawkins@MartenHawkins·
@CardiacRX Thanks Steven!! Always my hero! I’ve actually read memory, sorrow, thorn, but don’t think I’ve looked at the sequel so that’s perfect 😍
English
1
0
0
18
Marten Hawkins
Marten Hawkins@MartenHawkins·
Going on an extended vacay soon and looking for book recs. Prefer fantasy and completed series (I’m not a good wait-er 😫) but open to all! Help!!
English
2
0
1
160
Rob DiDomenico
Rob DiDomenico@robdeedo·
@StephDwyer21 Just in time for my lecture on ACS—Wednesday🙄 Surprised they wimped out on commenting about BB duration. Guess we’ll have to wait another 11-12 years…
English
2
0
7
482
Steven Dunn retweetledi
Dr. George
Dr. George@GeorgeAnagli·
According to the American Heart Association, ‘Not Like Us’ by Kendrick Lamar has the right tempo for Hands-Only CPR at 101 beats per minute.
Dr. George tweet mediaDr. George tweet media
English
6
23
258
6.7K
Steven Dunn
Steven Dunn@CardiacRX·
@kaulcsmc @drjohnm @AndrewFoy82 My take has always been dz-specific hospitalization first and foremost and all-cause is a more nonspecific marker of benefit. Need to dig into paper but my guess is margin of benefit may influence all-cause and also potential safety signal? Cool study - thanks for doing
English
2
0
4
565
Steven Dunn
Steven Dunn@CardiacRX·
Interrupting your regular dumpster fire of a feed to bring you the journal article title of the year (and also a cool paper): cjcopen.ca/article/S2589-…
English
0
0
13
440
Steven Dunn
Steven Dunn@CardiacRX·
@MartenHawkins I’ve mostly spent time in central Germany (and got married there) but Munich obv, Rothenburg if you want a cool historical town with a gigantic Christmas store with Kathe Wolfhart. Favorite Christmas markets are Nuremberg, Esslingen + Stuttgart and Mainz at night
English
1
0
1
195
Marten Hawkins
Marten Hawkins@MartenHawkins·
Which cities should I visit while in Germany in a few months?
English
1
0
0
225
Steven Dunn
Steven Dunn@CardiacRX·
@kaulcsmc @AnilMakam @cardiobrief @djc795 @drjohnm @PCORI I think the “change” was permission to stop using digoxin. I’d have to look at a time-based study but my guess is digoxin use has done from a 60+ percent use (early 2000’s) in chronic HF to <10% now. Part of it for sure is introduction of more effective therapies.
English
0
0
0
44
Sanjay Kaul
Sanjay Kaul@kaulcsmc·
@AnilMakam @cardiobrief @djc795 @drjohnm @PCORI I asked same Q 20 yrs ago! ALLHAT BP trial showing primacy of diuretic Rx SPRINT (I have been critical of this trial) in setting intensive BP lowering target ACCORD, VADT showing harm with intensive glycemic control FHS, establishing risk factors for ASCVD Any more to add?
English
3
0
1
296